A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction

A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction

Bibliographic Details
Main Authors: JI Weijia, YAN Xuebing
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2017-06-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=8249
id doaj-934b077cea584aa68000ffaedc1dad74
record_format Article
spelling doaj-934b077cea584aa68000ffaedc1dad742020-11-24T22:26:47ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562017-06-013361033103910.3969/j.issn.1001-5256.2017.06.003A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interactionJI Weijia0YAN Xuebing1Department of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, ChinaDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, Chinahttp://www.lcgdbzz.org/qk_content.asp?id=8249
collection DOAJ
language zho
format Article
sources DOAJ
author JI Weijia
YAN Xuebing
spellingShingle JI Weijia
YAN Xuebing
A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction
Linchuang Gandanbing Zazhi
author_facet JI Weijia
YAN Xuebing
author_sort JI Weijia
title A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction
title_short A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction
title_full A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction
title_fullStr A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction
title_full_unstemmed A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction
title_sort comparison of 2015 and 2016 easl guidelines on treatment of hepatitis c: an analysis of direct-acting antiviral agents and drug-drug interaction
publisher Editorial Department of Journal of Clinical Hepatology
series Linchuang Gandanbing Zazhi
issn 1001-5256
1001-5256
publishDate 2017-06-01
url http://www.lcgdbzz.org/qk_content.asp?id=8249
work_keys_str_mv AT jiweijia acomparisonof2015and2016easlguidelinesontreatmentofhepatitiscananalysisofdirectactingantiviralagentsanddrugdruginteraction
AT yanxuebing acomparisonof2015and2016easlguidelinesontreatmentofhepatitiscananalysisofdirectactingantiviralagentsanddrugdruginteraction
AT jiweijia comparisonof2015and2016easlguidelinesontreatmentofhepatitiscananalysisofdirectactingantiviralagentsanddrugdruginteraction
AT yanxuebing comparisonof2015and2016easlguidelinesontreatmentofhepatitiscananalysisofdirectactingantiviralagentsanddrugdruginteraction
_version_ 1725751560697282560

Similar Items